Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
0,0495 USD | +4,21% | +16,47% | -19,51% |
Métier
Nombre d'employés: 66
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Craig Jalbert
CEO | Chief Executive Officer | 63 | 21/11 |
Andrea Itano
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/17 |
Duncan McHale
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/02/18 |
Chun Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/17 |
Mark W. Bodmer
CTO | Chief Tech/Sci/R&D Officer | 69 | 19/01/16 |
Mark D. Plinio
PRN | Corporate Officer/Principal | 57 | 14/06/21 |
Corporate Officer/Principal | - | - | |
Julie Carretero
HRO | Human Resources Officer | - | 14/09/20 |
Stuart Abel
LAW | General Counsel | - | 01/01/19 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Craig Jalbert
CEO | Chief Executive Officer | 63 | 21/11 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 18 930 960 | 18 905 228 ( 99,86 %) | 0 | 99,86 % |
Coordonnées société
Evelo Biosciences, Inc.
One Kendal Square, 600/700 Suite 7-201
02139, Cambridge
+
http://www.evelobio.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
-19,51% | 940 k | |
-1,65% | 103 Md | |
+6,75% | 101 Md | |
+5,71% | 23,07 Md | |
-12,60% | 22,23 Md | |
-9,70% | 18,05 Md | |
-39,98% | 17,18 Md | |
-10,17% | 16,94 Md | |
+6,12% | 14,07 Md | |
+35,47% | 12,35 Md |
- Bourse
- Actions
- Action EVLO
- Société Evelo Biosciences, Inc.